Form D · Other Technology

Arable Labs, Inc.

San Francisco, CA · CIK 0001696488

Offering snapshot reported Jul 26, 2022 · SEC filing

Reported sold
$40.4M
Offering amount: $40.5M
Investors reported
15
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Feb 18, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 26, 2022Initial$40,389,048No comparison15SEC filing
Dec 4, 2020Initial$20,054,053No comparison13SEC filing
Aug 2, 2017Initial$2,999,000No comparison11SEC filing

Offering details

Securities
Equity, Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-453673
This filing covers the sale and issuance of Series C-1 Preferred Stock, the conversion of certain convertible promissory notes into Series C-2 Preferred Stock and the Common Stock issuable upon conversion of such Series C Preferred Stock.

Source: Form D, filed Jul 26, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ron Berg Executive
Brian Bolton Director
Mark Cupta Director
Anand Desai Executive
James Ethington Director, Executive
Tjarko Leifer Director
Brian Mixer Director
Sharelynn Moore Director
Saloni Multani Director
Cristina Rohr Director
Benjamin Siegfried Director
Adam Wolf Director, Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
51 Federal Street
San Francisco, CA, 94107